ImmunityBio
IBRX
IBRX
131 hedge funds and large institutions have $125M invested in ImmunityBio in 2022 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 54 increasing their positions, 33 reducing their positions, and 31 closing their positions.
Holders
131
Holders Change
-18
Holders Change %
-12.08%
% of All Funds
2.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
54
Reduced
33
Closed
31
Calls
$1.99M
Puts
$2.08M
Net Calls
-$95K
Net Calls Change
+$1.83M
Top Buyers
| 1 |
1
BlackRock
New York
|
$22M |
| 2 |
2
Millennium Management
New York
|
$4.39M |
| 3 |
3
Citadel Advisors
Miami,
Florida
|
$2.89M |
| 4 |
4
Mirae Asset Global Investments
Seoul,
South Korea
|
$2.34M |
| 5 |
5
Renaissance Technologies
New York
|
$1.49M |
